Back |
home / stock / ipci / ipci message board
Subject | By | Source | When |
---|---|---|---|
Hard to believe this bio company reached such | doogdilinger | investorshub | 06/10/2019 5:54:55 PM |
Intellipharmaceutics Announces Receipt of Cannabis Drug License from | doogdilinger | investorshub | 06/10/2019 5:48:58 PM |
Numbers- Odidi and company have certainly failed on | wimuskyfisherman | investorshub | 06/10/2019 5:08:38 PM |
$IPCI's Ranexa NOT among 4 FDA Approvals 5/28/2019. | numbersarefun | investorshub | 05/30/2019 4:46:55 PM |
Doog- Pretty crazy that $IPCI holds onto those | wimuskyfisherman | investorshub | 05/14/2019 7:36:47 PM |
The moment Odidiot got slammed and embarrassed by | doogdilinger | investorshub | 05/13/2019 7:41:29 PM |
Let the era of floorless toxic death spiral | doogdilinger | investorshub | 05/13/2019 7:13:59 PM |
Pristiq full approval today. Time to sell off | wimuskyfisherman | investorshub | 05/10/2019 8:09:51 PM |
Will be interesting to see how they come | wimuskyfisherman | investorshub | 05/02/2019 4:30:38 PM |
Intellipharmaceutics International Inc. (OTCQB: $IPCIF and TSX:$IPCI) (Intellipha | evenkeel | investorshub | 04/26/2019 3:35:34 PM |
Even- I read it the same way. | wimuskyfisherman | investorshub | 04/26/2019 12:58:57 PM |
If i read the last report correctly, they | evenkeel | investorshub | 04/25/2019 6:59:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Intellipharmaceutics International Inc. Company Name:
IPCI Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / March 19, 2019 / Intellipharmaceutics International Inc. (Nasdaq and TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-releas...
TORONTO, ON / ACCESSWIRE / March 4, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rele...
TORONTO, ON / ACCESSWIRE / February 22, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) (''Intellipharmaceutics'' or the ''Company''), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targe...